William Blair Investment Management
PRCT icon

William Blair Investment Management’s Procept Biorobotics PRCT Stock Holding History

William Blair Investment Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16M Buy
709,484
+285,175
+67% +$7.14M 0.05% 273
2026
Q1 		$10.6M Buy
424,309
+8,066
+2% +$227K 0.04% 313
2025
Q4 		$13.1M Buy
416,243
+33,226
+9% +$1.1M 0.04% 299
2025
Q3 		$13.7M Buy
383,017
+54,396
+17% +$2.48M 0.04% 305
2025
Q2 		$18.9M Buy
328,621
+7,317
+2% +$414K 0.05% 288
2025
Q1 		$18.7M Buy
321,304
+82,019
+34% +$5.6M 0.05% 301
2024
Q4 		$19.3M Buy
239,285
+26,783
+13% +$2.29M 0.05% 314
2024
Q3 		$17M Buy
+212,502
New +$15.1M 0.04% 311

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

William Blair Investment Management's PRCT Position: Q2 2026 in Review

William Blair Investment Management increased its Procept Biorobotics (PRCT) stake by 67% in Q2 2026, buying an estimated $7.14M and bringing the position to 709,484 shares worth $16M. The position accounts for 0.05% of the portfolio, ranked #273.

William Blair Investment Management first reported a position in PRCT in Q3 2024 and has held it in 8 quarters since. The position peaked at $19.3M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • William Blair Investment Management held 709,484 shares of Procept Biorobotics worth $16M as of Q2 2026.
  • William Blair Investment Management bought 285,175 Procept Biorobotics shares in Q2 2026, an estimated $7.14M.
  • Procept Biorobotics made up 0.05% of William Blair Investment Management's portfolio in Q2 2026, its #273 holding.
  • William Blair Investment Management first reported a position in Procept Biorobotics in Q3 2024 and has held it in 8 quarters since.
  • William Blair Investment Management's Procept Biorobotics position peaked at $19.3M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on William Blair Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.